SEC Filing: Form 10-Q
Quarterly report [Sections 13 or 15(d)]
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Quarterly report [Sections 13 or 15(d)]
Statement of acquisition of beneficial ownership by individuals
Registration of securities, business combinations – amendment
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities